FDAFDA · Food and drugs·Recall number D-1863-2019
Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle, Rx Only, Distr. by: West-Ward Pharmaceuticals,Eatontown, NJ. NDC:0054-0199-59
Published September 25, 2019 · Recall initiated: September 9, 2019
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specificattion
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- West-Ward Columbus Inc
- Distributor
- Nationwide USA and Puerto Rico
- Lot
- Lot, expiry: Lots AA3957A, AA3958A, exp May 2020; Lot AA5164A, exp Sep 2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.